Main
>
PNEUMOLOGY
>
Asthma
>
Treatment
>
DaclizuMAb (IL-2 Inhibitor)
>
Co.: USA. A. (Phase II/Patents)
>
Patent>Total USA No.: 4
Patent>Total USA No.: 4's products
This section has no products